1. Al-Batran SE, Hartmann JT, Hofheinz R et al (2010) Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie. Ann Oncol 2008; 19: 1882–1887
2. Bang YJ, van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687–697
3. Correa P (1992) Human gastric carcinogenesis: a multi step and multi factorial process – first American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res 52(24):6735–6740
4. de Martel C, Franceschi S (2009) Infections and cancer: established associations and new hypotheses. Crit Rev Oncol Hematol 70(3):183–194
5. Ebert M, Schepp W, Engel J, Janetschek P, Adam M, Schulz C, Vogelsang H, Schlitter AM, Esposito I, Schuhmacher C (2010) Magenkarzinom. In: MANUAL Gastrointestinale Tumore. Tumorzentrum München/W. Zuckschwerdt Verlag, München